Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to identify the concentration and daily dosing frequency of
BOL-303242-X ophthalmic suspension in treating dry eye syndrome over a 12 week dosing period.